Related Experiment Video
Updated: Oct 3, 2025

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice
Published on: July 8, 2020
Urinary C5b-9 as a Prognostic Marker in IgA Nephropathy
Byung Chul Yu1, Jin Hoon Park1, Kyung Ho Lee1
1Division of Nephrology, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, 170 Jomaru-ro, Bucheon 14584, Korea.
Insights
Urinary C5b-9 levels correlate with proteinuria and kidney function changes in IgA nephropathy (IgAN) patients. However, urinary C5b-9 is not yet a reliable prognostic biomarker for IgAN outcomes.
Area of Science:
- Nephrology
- Immunology
- Biomarker Research
Background:
- Immunoglobulin A nephropathy (IgAN) pathogenesis involves the complement system, specifically the terminal complement complex C5b-9.
- Evaluating novel biomarkers is crucial for predicting IgAN progression and treatment response.
Purpose of the Study:
- To assess the prognostic value of urinary C5b-9 levels in patients with IgAN.
- To investigate the correlation between urinary C5b-9 and clinical outcomes, including proteinuria and estimated glomerular filtration rate (eGFR).
Main Methods:
- Prospective enrollment of 33 patients with biopsy-proven IgAN.
- Analysis of baseline and post-treatment urinary C5b-9 levels.
- Correlation analysis with proteinuria, eGFR changes, and treatment response.
Main Results:
- Baseline urinary C5b-9 positively correlated with proteinuria at diagnosis (r = 0.548, p = 0.001).
- Post-treatment changes in urinary C5b-9 correlated with proteinuria and inversely with eGFR changes at 6 months.
- Urinary C5b-9 changes correlated with time-averaged proteinuria but not eGFR decline rate.
- Baseline urinary C5b-9 was not an independent predictor of treatment response (OR 0.997, p = 0.078).
Conclusions:
- Urinary C5b-9 shows correlations with proteinuria and kidney function parameters in IgAN.
- Current evidence suggests urinary C5b-9 is not a sufficiently promising prognostic biomarker for IgAN.
- Further research is warranted to explore the role of urinary C5b-9 in IgAN.
Abstract:
C5b-9 plays an important role in the pathogenesis of immunoglobin A nephropathy (IgAN). We evaluated C5b-9 as a prognostic marker for IgAN. We prospectively enrolled 33 patients with biopsy-proven IgAN. We analyzed the correlation between baseline urinary C5b-9 levels, posttreatment changes in their levels, and clinical outcomes, including changes in proteinuria, estimated glomerular filtration rate (eGFR), and treatment response. Baseline urinary C5b-9 levels were positively correlated with proteinuria (r = 0.548, p = 0.001) at the time of diagnosis. Changes in urinary C5b-9 levels were positively correlated with changes in proteinuria (r = 0.644, p < 0.001) and inversely correlated with changes in eGFR (r = -0.410, p = 0.018) at 6 months after treatment. Changes in urinary C5b-9 levels were positively correlated with time-averaged proteinuria during the follow-up period (r = 0.461, p = 0.007) but were not correlated with the mean annual rate of eGFR decline (r = -0.282, p = 0.112). Baseline urinary C5b-9 levels were not a significant independent factor that could predict the treatment response in logistic regression analyses (odds ratio 0.997; 95% confidence interval, 0.993 to 1.000; p = 0.078). Currently, urinary C5b-9 is not a promising prognostic biomarker for IgAN, and further studies are needed.
More Related Videos
14:18Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
Published on: October 13, 2023
09:43Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Related Concept Videos
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Nephrotic Syndrome II : Assessment and Medical Management
Urine Studies I: Urinalysis
Serum Studies: Renal Function Tests